Medicare Monday: What they are saying about MedPAC ’s Part B recommendations

Last week, the Medicare Payment Advisory Commission (MedPAC) voted on a number of recommendations affecting Medicare Part B. These proposed changes could negatively impact patients ’ access to Part B medicines that are used to treat complex and serious conditions, like cancer, rheumatoid arthritis and mental illness, among others. In case you missed it, we looked at theserecommendations ahead of the vote.
Source: The Catalyst - Category: Pharmaceuticals Tags: Medicare Medicare Monday Part B Source Type: news